abstract |
The present invention also relates to the use of such compounds in the treatment of diseases or disorders mediated by the activity of MDM2 and / or MDM4, pharmaceutical formulations comprising such compounds, compounds of formula (I) as described herein, ≪ / RTI > compounds. (I) |